Doceree Adds Clinical Intent Tracking Tech to Upcoming AI Platform

Ahead of the rollout of its artificial intelligence-powered life sciences commercialization platform next month, Doceree this week unveiled a new feature aimed at helping pharma and healthcare marketers monitor and act on HCP behaviors in real time. 

The Clinical Intent Signals (CIS) intelligence software will be available for addition to the Daily Command platform upon its July 14 launch. 

Doceree is billing CIS as a way for marketers to strengthen HCP engagement with their omnichannel campaigns. The tool gives them access to real-time data on digital indicators of clinical intent—like searches, content consumption and workflow patterns—gathered from EHRs, medical journals, point-of-care platforms and other sources.  

From there, marketers can use CIS to target specific clinicians via various campaign channels as the HCPs are actively in the process of making prescribing and other treatment decisions, rather than basing outreach on traditional retrospective or static data sources. 

According to Doceree’s Tuesday release, a 12-week pilot of the technology spanning 36,000 HCPs found that campaigns using CIS were able to speed up progression through the HCP decision journey by 38%, while also reporting an average 27% improvement in contextual engagement and 21% boost in media efficiency. 

CIS will be available through both subscription and usage-based tiers within the Daily Command platform. Doceree pulled back the curtain on the platform last month, touting it as a unified ecosystem for planning, executing and measuring marketing work, built with input from senior leaders representing major pharmas and agencies like Sanofi, Eli Lilly, Deerfield, Omnicom Health Group and more. 

solli’s Final Thoughts 

Effectively reaching HCPs, the primary gatekeepers of clinical decision-making and patient trust, has long been a crucial piece of the pharma marketing puzzle, though complicated by clinicians’ busy schedules, fragmented attention and strict compliance rules. 

As HCP engagement remains a key cornerstone of pharma media—made even more so by the currently precarious state of DTC marketing—Doceree is among other leading tech developers introducing new tools that attempt to optimize HCP engagement. 

At the core of many of these offerings are promises of sharper, more precise data analytics, often powered by AI, that not only aim to improve audience targeting, but also zoom in even further to pinpoint the exact moment a specific clinician may be most receptive to a personalized campaign message.